The 95% confidence interval (CI) of gender, pathological type, IDH status, 1p/19q deletion, and EMP3 expression level all crossed one, and these five factors had no significant impact on the OS of glioma patients (p > 0.05). The gene discussed is IDH1; the disease is central nervous system cancer.